In Brief: DHEA study
This article was originally published in The Tan Sheet
Executive Summary
DHEA study: Double-blind clinical trial to study the effect of 100 mg/day doses of DHEA in Alzheimer's patients is being extended by two months and adding subjects with an additional grant from the sponsor, Neurocrine Biosciences. The study, originally scheduled to last six months, is being conducted by Owen Wolkowitz, MD at the University of California-San Francisco and should provide results by the end of 1997 ("The Tan Sheet" Aug. 12, p. 6)...